reports
Dentsply Sirona Reports First Quarter 2024 Results
Dentsply Sirona Reports First Quarter 2024 Results Net sales of $953 million decreased (2.6%), organic sales decreased (1.9%)GAAP gross margin of 53.1%, GAAP net income of $18 million or $0.09 per shareAdjusted EBITDA margin of 16.8%, adjusted EPS of $0.42Maintaining FY24 outlook for organic sales and adjusted EPS, trending towards the low-end of both ranges; reported sales adjusted for additional foreign currency impactCompany expects to repurchase up to $150 million of its common stock in Q2 2024 CHARLOTTE, N.C, May 02, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” o...
Dentsply Sirona to Host First Quarter Conference Call on May 2nd
Dentsply Sirona to Host First Quarter Conference Call on May 2nd CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company’s website at Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company’s we...
Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board ...
Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company’s Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election. Mr. Brandt commented, “As I think back on the past two decades and all ...
Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Pro...
Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend FY23 net sales of $3,965 million increased 1.1%, organic sales increased 2.2%FY23 GAAP net income (loss) of ($132) million or ($0.62) per share, adjusted EPS of $1.83Q4 net sales of $1,012 million increased 2.9%, organic sales increased 1.9%Q4 GAAP net income of $67 million or $0.32 per share, adjusted EPS of $0.44FY24 outlook: organic sales flat to up 1.5%; adjusted EPS of $2.00 to $2.10 CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Si...
Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference C...
Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results. A presentation related to the call will be available on the Investors section of the Company’s website at . Conference Call / Webcast Information A live webcast will be a...
Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provi...
Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company’s previously provided outlook range of $...
Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare C...
Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare Conference Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentsp...
Dentsply Sirona Declares Quarterly Cash Dividend
Dentsply Sirona Declares Quarterly Cash Dividend CHARLOTTE, N.C., Dec. 21, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share of common stock, an indicated annual rate of $0.56 per share. The dividend is payable on January 12, 2024, to holders of record as of December 29, 2023. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service t...
- Jonathan Moreland
ITW ILLINOIS TOOL WORKS INC.
XRAY DENTSPLY SIRONA INC.
TNDM TANDEM DIABETES CARE INC
TCBI TEXAS CAPITAL BANCSHARES INC.
STAA STAAR SURGICAL CO.
SHBI SHORE BANCSHARES INC.
MRCY MERCURY SYSTEMS INC.
LMAT LEMAITRE VASCULAR INC.
KMPR KEMPER CORPORATION
GABC GERMAN AMERICAN BANCORP
BMY BRISTOL-MYERS SQUIBB COMPANY
AMRC AMERESCO
FMC FMC CORPORATION
HTLD HEARTLAND EXPRESS INC.
OESX ORION ENERGY SYSTEMS INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
CTHR CHARLES & COLVARD LTD.
PLSE PULSE BIOSCIENCES
VRNA VERONA PHARMA ADS
LAZY LAZYDAYS HOLDINGS
SPB SPECTRUM BRANDS HOLDINGS INC.
AXR AMREP
ATRI ATRION CORPORATION
ITRM ITERUM THERAPEUTICS
ZM ZOOM VIDEO COMMUNICATIONS
ATEX INC.
KSM ANTERIX
PTON DWS STRATEGIC MUNICIPAL INCOME TRUST
GDRX PELOTON INTERACTIVE
ONDS INC.
AGL GOODRX HOLDINGS
AUID INC.
AUGX ONDAS HOLDINGS
VWE AGILON HEALTH
VTRS INC.
SGHT IPSIDY INC.
VPV AUGMEDIX
CYT INC.
FTK VINTAGE WINE ESTATES INC
CEV VIATRIS INC
SEEL SIGHT SCIENCES INC
INVESCO PA VALUE MUNI INC TST
CYTEIR THERAPEUTICS INC
FLOTEK INDUSTRIES INC.
EATON VANCE CALIFORNIA MUN INC TRST
SENTINEL ELECTRONICS
- Jonathan Moreland
Dentsply Sirona Inc: 1 director
A director at Dentsply Sirona Inc bought 10,000 shares at 31.440USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
- Jonathan Moreland
TRU TRANSUNION
TCBI TEXAS CAPITAL BANCSHARES INC.
HRTX HERON THERAPEUTICS INC
GLP GLOBAL PARTNERS LP
GABC GERMAN AMERICAN BANCORP
EMR EMERSON ELECTRIC CO.
DAR DARLING INGREDIENTS INC.
COMM COMMSCOPE HOLDING CO. INC.
BMY BRISTOL-MYERS SQUIBB COMPANY
AMRC AMERESCO
ASA ASA
EVA ENVIVA PARTNERS LP
ENPH ENPHASE ENERGY INC.
HTLD HEARTLAND EXPRESS INC.
FLL FULL HOUSE RESORTS INC.
ADES
VERI ADVANCED EMISSIONS SOLUTIONS
MDGL VERITONE INC.
MHI MADRIGAL PHARMACEUTICALS
ESTA PIONEER MUNICIPAL HIGH INCOME TRUST
KSM ESTABLISHMENT LABS HOLDINGS
NVST DWS STRATEGIC MUNICIPAL INCOME TRUST
PTON ENVISTA HOLDINGS
GCI PELOTON INTERACTIVE
VTN INC.
DCTH GANNETT CO. INC.
ENX INVESCO TRUST FOR INVESTMENT G
GRPN DELCATH SYSTEMS
ONDS EATON VANCE NEW YORK MUNICIPAL BOND FUND
AGL GROUPON INC.
GEG ONDAS HOLDINGS
FTCI AGILON HEALTH
AUID INC.
AUGX GREAT ELM GROUP INC
SOFI FTC SOLAR
HYLN INC.
ATNI IPSIDY INC.
CYT AUGMEDIX
INC.
SOFI TECHNOLOGIES INC
HYLIION HOLDINGS CORP.
ATLANTIC TELE-NETWORK
INC.
CYTEIR THERAPEUTICS INC
- Jonathan Moreland
TRU TRANSUNION
HRTX HERON THERAPEUTICS INC
EMR EMERSON ELECTRIC CO.
DAR DARLING INGREDIENTS INC.
ENPH ENPHASE ENERGY INC.
FLL FULL HOUSE RESORTS INC.
ADES
VERI ADVANCED EMISSIONS SOLUTIONS
ESTA VERITONE INC.
NVST ESTABLISHMENT LABS HOLDINGS
GCI ENVISTA HOLDINGS
DCTH GANNETT CO. INC.
GRPN DELCATH SYSTEMS
GROUPON INC.
Dentsply Sirona to Participate in Upcoming Investor Conferences
Dentsply Sirona to Participate in Upcoming Investor Conferences CHARLOTTE, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Jefferies 2023 London Healthcare Conference on November 15, 2023, at 8:30 am GMT6th Annual Evercore ISI HealthCONx Conference on November 29, 2023, at 8:00 am ET Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About ...
Dentsply Sirona to Host its Investor Day and Introduce Three-Year Fina...
Dentsply Sirona to Host its Investor Day and Introduce Three-Year Financial Targets CHARLOTTE, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will host its Investor Day today at the Company’s headquarters in Charlotte, N.C. The event will begin at 8:30 AM ET. The event will include presentations from members of its executive management team, live Q&A, and panel discussions with commercial leaders and customers. As part of the event, the Company will introduce three-year financial targets including details of its plan to ...
Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Boar...
Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the “Board”), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.’s retirement on December 31, 2023. “On behalf of Dentsply Sirona and the Board of Directors, I am pleased to welcome Brian Gladden to the Board,” said Eric K. Brandt, Non-Executive Chairman of the Board. “Br...
Dentsply Sirona Reports Third Quarter 2023 Results
Dentsply Sirona Reports Third Quarter 2023 Results Net sales of $947 million were flat year-over-year, organic sales decreased (0.3%)GAAP gross margin of 52.2%, GAAP net loss of ($266) million or ($1.25) per shareAdjusted EBITDA margin of 18.2%, adjusted EPS of $0.49Revised FY23 outlook: organic sales growth of ~1% (from ~3%); adjusted EPS of $1.80 to $1.85 (from $1.92 to $2.02)Company expects to repurchase $150 million of its common stock in Q4 2023 CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today ann...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.